FDA approves Purdue Pharma’s Palladone
hydrochloride) capsules for the management of persistent moderate
to severe pain in patients requiring continuous opioid pain
relief for an extended period of time.
Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.
The FDA has approved Arnuity Ellipta for asthma.
An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...